InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Szekeres David Leslie, Chief Executive Officer. Officer active across 2 companies, notably Heron Therapeutics, INC.. In total, 9 disclosures have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 31 October 2022 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Szekeres David Leslie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,250 sharesCommon StockSEC:0001209191-23-042480:0
1,250 sharesCommon StockSEC:0001209191-23-024500:0
1,654 shares@ US$3.272549.7% of flowCommon StockSEC:0001209191-23-003564:0
1,250 sharesCommon StockSEC:0001209191-22-053836:0
1,505 shares@ US$3.84250.3% of flowCommon StockSEC:0001209191-22-042263:0
1,250 sharesCommon StockSEC:0001209191-22-024523:0
1,250 sharesCommon StockSEC:0001209191-22-003364:0
1,250 sharesCommon StockSEC:0001209191-21-060553:0
1,530 shares@ US$13.8975100.0% of flowCommon StockSEC:0001209191-21-046791:0
9 of 9 declarations
About Szekeres David Leslie
Szekeres David Leslie is a Director General. He has filed 9 filings in total. In the 9 recent filings we hold, the most common transaction nature is option exercise, the date range runs from 2021-07-15 to 2023-07-17, and the euro amounts published include 17533.61828401656, 5504.663935748968, and 5437.185887199782.
